美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,401.53

+23.961.74%

涨家数：13

跌家数：6

平家数：1

市盈率：- -

高：1,412.65

开：1,378.08

低：1,377.97

收：1,377.58

数据加载中...

Alpha Pro Tech, Ltd.盘中异动下午盘股价大涨5.12%报4.93美元

Vir Biotechnology, Inc.盘中异动股价大涨5.16%

莫德纳盘中异动临近午盘股价大涨5.02%报28.98美元

阿斯利康首席执行官考虑在美股上市

环球市场播报

强生盘中异动早盘快速上涨3.01%

Co-Diagnostics, Inc.盘中异动快速上涨7.07%报0.300美元

美股异动 | 医药板块逆市走高 Moderna(MRNA.US)涨超1.6%

阿斯利康ADR涨幅迅速扩大至2.67%刷新日高，伦敦股价涨1.2%刷新日高。

阿斯利康CEO据悉已经讨论将上市地迁往美国的可能性。

阿斯利康ADR涨幅迅速扩大至2.67%刷新日高伦敦股价涨1.2%刷新日高。

阿斯利康首席执行官已讨论将公司上市地点迁至美国。

Corvus Pharmaceuticals, Inc.盘中异动早盘股价大跌5.00%

伊诺维奥制药盘中异动早盘股价大跌5.16%

BUZZ-CMS 提出招标计划变更后，糖尿病设备制造商业绩下滑

从康辰药业KC1086看KAT6靶向药潜力：辉瑞、恒瑞等药企抢滩，或攻克CDK4/6耐药

CPHI制药在线

Moderna mRNA流感疫苗3期临床获积极结果，效力超传统疫苗26.6%

阿斯利康在北京成立全球研发公司注册资本8000万

9款重磅疗法上市！2025上半年获批肺癌新药全盘点

辉瑞6月30日成交额为10.85亿美元

诺瓦瓦克斯医药6月30日成交额为2298.66万美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1401.5334,"timestamp":1751399999999,"preClose":1377.5769,"halted":0,"volume":123561910,"delay":0,"changeRate":0.01739,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":23.956543,"latestTime":"07-01 16:00:00 EDT","open":1378.0804,"high":1412.6465,"low":1377.9702,"amount":5792057559.179062,"amplitude":0.025172,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1751414400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.632214,"peRate":21.648264,"turnoverRate":0.007961,"increases":13,"decrements":6,"flats":1,"marketCap":1155523357518.75,"floatMarketCap":1135055916739.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1412.6465,"amplitude":0.025172,"preClose":1377.5769,"low":1377.9702,"pbRate":"3.632214","latestPrice":1401.5334,"volume":123561910,"delay":0,"open":1378.0804,"prevYearClose":1274.8187,"prevWeekClose":1372.5472,"prevMonthClose":1377.5769,"prevQuarterClose":1377.5769,"fiveDayClose":1377.6726,"twentyDayClose":1380.7695,"sixtyDayClose":1401.546,"secType":"PLATE","market":"US","turnoverRate":0.007961,"peRate":21.648264,"marketCap":1155523357518.75,"floatMarketCap":1135055916739.5,"timestamp":1751399999999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":13,"down":6,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548881546","title":"Alpha Pro Tech, Ltd.盘中异动 下午盘股价大涨5.12%报4.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548881546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548881546?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 02:00","pubTimestamp":1751392818,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日02时00分，Alpha Pro Tech, Ltd.股票出现异动，股价急速上涨5.12%。截至发稿，该股报4.93美元/股，成交量1.4138万股，换手率0.13%，振幅4.44%。Alpha Pro Tech, Ltd.股票所在的建筑设备行业中，整体涨幅为1.05%。Alpha Pro Tech, Ltd.公司简介：Alpha Pro Tech Ltd从事保护人员、产品和环境的业务。它还生产一系列建筑耐候产品，这些产品以Alpha Pro Tech品牌销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702020018a4c96d1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702020018a4c96d1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4086","APT"],"gpt_icon":0},{"id":"2548868018","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548868018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548868018?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 00:20","pubTimestamp":1751386819,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时20分，Vir Biotechnology, Inc.股票出现异动，股价急速上涨5.16%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070200201997961ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070200201997961ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","VIR","BK4535","BK4139","BK4585"],"gpt_icon":0},{"id":"2548883909","title":"莫德纳盘中异动 临近午盘股价大涨5.02%报28.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548883909?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 23:46","pubTimestamp":1751384819,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时46分，莫德纳股票出现波动，股价大幅拉升5.02%。截至发稿，该股报28.98美元/股，成交量458.882万股，换手率1.19%，振幅7.76%。莫德纳股票所在的生物技术行业中，整体涨幅为1.08%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012347009532bd71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012347009532bd71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4533","BK4551","BK4588","BK4532","BK4548","BK4534","MRNA","BK4139","BK4585","BK4501"],"gpt_icon":0},{"id":"2548888738","title":"阿斯利康首席执行官考虑在美股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2548888738","media":"环球市场播报","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548888738?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 23:24","pubTimestamp":1751383459,"startTime":"0","endTime":"0","summary":"《泰晤士报》周二援引多位消息人士的话报道称，阿斯利康首席执行官帕斯卡尔・索里奥特正考虑将公司的股票上市地点迁至美国。\n　　该公司尚未立即回应路透社的置评请求。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-07-01/doc-infcytxf5210485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4568","LU0320765992.SGD","LU2456880835.USD","LU0109394709.USD","LU2462157665.USD","BK4588","LU2236285917.USD","LU1829250122.USD","AZN","LU2417539215.USD","BK4585","LU0889565916.HKD","BK4007"],"gpt_icon":0},{"id":"2548886806","title":"强生盘中异动 早盘快速上涨3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548886806?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 23:13","pubTimestamp":1751382791,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时13分，强生股票出现波动，股价快速拉升3.01%。截至发稿，该股报157.36美元/股，成交量242.753万股，换手率0.10%，振幅2.85%。强生股票所在的制药行业中，整体涨幅为0.90%。其相关个股中，Citius Oncology, Inc.、Medicus Pharma Ltd C/Wts 15/11/2029、坎伯兰药业涨幅较大，Incannex Healthcare Inc.、Inmed Pharmaceuticals Inc.、Biofrontera Inc.较为活跃，换手率分别为8.43%、4.50%、1.77%，振幅较大的相关个股有Citius Oncology, Inc.、Therapeuticsmd, Inc.、Shuttle Pharmaceuticals Holdings, Inc.，振幅分别为21.84%、18.87%、17.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701231311a728b7a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701231311a728b7a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0466842654.USD","IE00B19Z3B42.SGD","SG9999001440.SGD","BK4533","LU1718418525.SGD","IE00B3PB1722.GBP","LU1894683348.USD","BK4581","LU0345769128.USD","LU2505996681.GBP","SG9999002232.USD","LU1221951046.USD","LU0234572021.USD","LU0985320562.USD","BK4532","LU0795875086.SGD","LU1280957306.USD","BK4568","LU1221951129.SGD","LU2089984988.USD","IE00BLSP4452.SGD","LU2133065610.SGD","IE00B1BXHZ80.USD","LU2112291526.USD","BK4550","IE00BN8TJ469.HKD","LU1778281490.HKD","LU0203345920.USD","IE00BVYPNV92.GBP","LU0889566641.SGD","LU1732799900.SGD","LU0122379950.USD","LU2347655156.SGD","IE0009355771.USD","LU1674673428.USD","IE0034235303.USD","LU2129689514.USD","LU2430703178.SGD","IE00BLSP4239.USD","IE00BFXG1179.USD","LU1059921491.USD","LU1244550494.USD","LU1732800096.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","JNJ","LU1162221912.USD","IE0002141913.USD","LU0289739699.SGD","BK4585"],"gpt_icon":0},{"id":"2548888216","title":"Co-Diagnostics, Inc.盘中异动 快速上涨7.07%报0.300美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548888216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548888216?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 23:03","pubTimestamp":1751382218,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时03分，Co-Diagnostics, Inc.股票出现异动，股价快速拉升7.07%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体涨幅为0.13%。其相关个股中，Envoy Medical Inc C/Wts 29/09/2028 、Heartsciences Inc C/Wts 、Vivos Therapeutics, Inc.涨幅较大，Vivos Therapeutics, Inc.、Bone Biologics Corp、Helius Medical Technologies, Inc.较为活跃，换手率分别为385.83%、28.02%、18.00%，振幅较大的相关个股有Vivos Therapeutics, Inc.、Helius Medical Technologies, Inc.、Dih Holding Us, Inc.，振幅分别为35.76%、20.72%、13.19%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701230338a4c93dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701230338a4c93dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2548883087","title":"美股异动 | 医药板块逆市走高 Moderna(MRNA.US)涨超1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883087","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548883087?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 23:02","pubTimestamp":1751382146,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，美股医药板块逆市走高，截至发稿，Moderna(MRNA.US)涨超1.6%，礼来(LLY.US)涨0.85%，诺和诺德(NVO.US)涨超1.2%，联合健康(UNH.US)涨超3.9%，辉瑞(PFE.US)涨超3.4%。消息面上，此前Moderna宣布其mRNA流感疫苗 mRNA-1010在关键3期临床试验中取得重磅进展，在针对50岁及以上成年人的研究中，该疫苗相对传统获批流感疫苗的效力提升26.6%，标志着mRNA技术在流感预防领域的重大突破。这一成果不仅为Moderna叩开监管审批大门注入新动能，更推动其流感/COVID联合疫苗研发迈出关键一步。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4568","BK1515","BK4533","09939","BK4551","BK4588","BK1161","BK4532","BK4548","159938","BK4534","MRNA","BK4139","BK1574","BK4501"],"gpt_icon":0},{"id":"2548000750","title":"阿斯利康ADR涨幅迅速扩大至2.67%刷新日高，伦敦股价涨1.2%刷新日高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000750","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548000750?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 22:44","pubTimestamp":1751381084,"startTime":"0","endTime":"0","summary":"阿斯利康ADR涨幅迅速扩大至2.67%刷新日高，伦敦股价涨1.2%刷新日高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/01224451424848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4568","LU0320765992.SGD","LU2456880835.USD","LU0109394709.USD","LU2462157665.USD","BK4588","LU2236285917.USD","LU1829250122.USD","AZN","LU2417539215.USD","BK4585","LU0889565916.HKD","BK4007"],"gpt_icon":0},{"id":"2548000438","title":"阿斯利康CEO据悉已经讨论将上市地迁往美国的可能性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000438","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548000438?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 22:43","pubTimestamp":1751380989,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2456880835.USD","LU2462157665.USD","LU0109394709.USD","AZN","BK4568","LU2236285917.USD","BK4585","LU2417539215.USD","LU0320765992.SGD","BK4007","LU0889565916.HKD","LU1829250122.USD","BK4588"],"gpt_icon":0},{"id":"2548000435","title":"阿斯利康ADR涨幅迅速扩大至2.67%刷新日高伦敦股价涨1.2%刷新日高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548000435?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 22:42","pubTimestamp":1751380921,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU0889565916.HKD","BK4588","LU0320765992.SGD","AZN","LU2456880835.USD","LU2417539215.USD","LU2236285917.USD","LU2462157665.USD","LU0109394709.USD","BK4568","LU1829250122.USD","BK4007"],"gpt_icon":0},{"id":"2548000132","title":"阿斯利康首席执行官已讨论将公司上市地点迁至美国。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000132","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548000132?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 22:38","pubTimestamp":1751380723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2417539215.USD","LU0109394709.USD","LU2462157665.USD","LU2456880835.USD","LU0889565916.HKD","BK4007","BK4588","LU2236285917.USD","LU1829250122.USD","BK4568","LU0320765992.SGD","AZN","BK4585"],"gpt_icon":0},{"id":"2548600058","title":"Corvus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548600058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548600058?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 22:28","pubTimestamp":1751380119,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日22时28分，Corvus Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.00%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家处于临床阶段的生物制药公司，致力于开发精准靶向对免疫细胞成熟和功能至关重要的蛋白质的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012228399796034a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012228399796034a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","CRVS"],"gpt_icon":0},{"id":"2548002521","title":"伊诺维奥制药盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548002521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548002521?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 21:36","pubTimestamp":1751376997,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日21时36分，伊诺维奥制药股票出现波动，股价大幅下跌5.16%。截至发稿，该股报1.93美元/股，成交量7.0141万股，换手率0.19%，振幅3.93%。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.04%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。该公司专注于开发和商业化 DNA 药物，以帮助治疗和保护人们免受 HPV 相关疾病、癌症和传染病的侵害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701213637a4c91c04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701213637a4c91c04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4583","INO"],"gpt_icon":0},{"id":"2548064870","title":"BUZZ-CMS 提出招标计划变更后，糖尿病设备制造商业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2548064870","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548064870?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 20:02","pubTimestamp":1751371376,"startTime":"0","endTime":"0","summary":"BUZZ-CMS 提出招标计划变更后，糖尿病设备制造商业绩下滑7月1日 -  ** 糖尿病设备制造商 DexCom DXCM.O 和 Tandem Diabetes Care TNDM.O 的股价盘前分别下跌近 4 ** DXCM 下跌3.8%，报84美元，TNDM下跌3.9%，报17.92美元 ** 美国医疗保险与医疗补助服务中心周一晚些时候提议修改竞争性招标计划，旨在降低糖尿病 患者购买胰岛素泵、连续血糖监测仪 和其他设备的共付额。** 摩根大通称，这些变化将影响到生产 CGM 的雅培ABT.N和 DXCM，以及 胰岛素泵制造商 TNDM 和 Beta Bionics BBNX.O。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL4S3SY0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMPRXR70.SGD","BK4566","BK4568","LU2089984988.USD","LU2237957902.USD","TNDM","SGXZ23171101.USD","LU2433249047.HKD","BK4534","LU2211815571.USD","IE00BMPRXN33.USD","LU0170899867.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2133065610.SGD","LU2468319806.SGD","LU2237957811.SGD","LU1691799644.USD","LU1989763427.SGD","SG9999002224.SGD","IE00BFTCPJ56.SGD","LU0354030511.USD","SG9999004303.SGD","LU1914381329.SGD","LU1721429741.USD","LU0266013472.USD","LU2125909593.SGD","IE00BJT1NW94.SGD","BK4592","BK4082","IE0009355771.USD","LU0122379950.USD","IE00B2B36J28.USD","BK4548","ABT","LU0234572021.USD","LU1989763690.USD","BK4533","LU1923622614.USD","LU0354030438.USD","BK4588","SG9999002232.USD","LU1057294990.SGD","LU0868494617.USD","LU1323610961.USD","BBNX","LU2125909247.SGD","DXCM","BK4581","BK4585"],"gpt_icon":0},{"id":"2548003569","title":"从康辰药业KC1086看KAT6靶向药潜力：辉瑞、恒瑞等药企抢滩，或攻克CDK4/6耐药","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003569","media":"CPHI制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548003569?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 18:35","pubTimestamp":1751366118,"startTime":"0","endTime":"0","summary":"因此，KAT6被认为是肿瘤药研发的潜力靶点。此外，KAT6靶向药领域已有BD交易达成。总结整体来看，KAT6靶向药大多处于早期阶段，辉瑞的PF-07248144预计有望最先进入3期临床。适应症上看，当前KAT6靶向药主要集中在乳腺癌，有望攻克CDK4/6抑制剂耐药问题。期待KAT6靶向药早日迎来重大突破，造福广大肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185313a4c8d3e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185313a4c8d3e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4568","LU0456855351.SGD","LU1894683348.USD","SG9999002224.SGD","LU0122379950.USD","SG9999013999.USD","LU0985481810.HKD","IE00B19Z3581.USD","LU0321505439.SGD","LU1066051498.USD","BK4581","BK4007","IE0002270589.USD","SG9999003800.SGD","603590","01276","SGXZ57979304.SGD","LU0234572021.USD","PFE","LU1883839398.USD","BK4533","BK4585","LU0170899867.USD","LU0306807586.USD","BK4588","LU1066053197.SGD","SG9999011175.SGD","BK4534","IE00BLSP4239.USD","LU1057294990.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU1023059063.AUD","BK4592","IE00BBT3K403.USD","SG9999002232.USD","LU0058720904.USD","LU0289739699.SGD","BK4550","LU0868494617.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0225284248.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU0306806265.USD","LU0321505868.SGD","SG9999001176.USD","600276"],"gpt_icon":1},{"id":"2548407245","title":"Moderna mRNA流感疫苗3期临床获积极结果，效力超传统疫苗26.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548407245","media":"医药时间","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548407245?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 16:55","pubTimestamp":1751360130,"startTime":"0","endTime":"0","summary":"今日，Moderna 宣布其 mRNA 流感疫苗 mRNA-1010 在关键 3 期临床试验中取得重磅进展 —— 在针对 50 岁及以上成年人的研究中，该疫苗相对传统获批流感疫苗的效力提升 26.6%，标志着 mRNA 技术在流感预防领域的重大突破。临床数据：全方位超越传统疫苗Moderna 在11个国家纳入 40805 名受试者的试验中证实，mRNA-1010 对三种主要流感毒株均展现强效保护。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701171557a728191f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701171557a728191f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4533","BK4551","BK4535","BK4588","BK4532","BK4548","BNTX","BK4534","MRNA","BK4139","BK4585","BK4501"],"gpt_icon":0},{"id":"2548807361","title":"阿斯利康在北京成立全球研发公司 注册资本8000万","url":"https://stock-news.laohu8.com/highlight/detail?id=2548807361","media":"天眼查","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548807361?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 14:55","pubTimestamp":1751352954,"startTime":"0","endTime":"0","summary":"（原标题：阿斯利康在北京成立全球研发公司 注册资本8000万）天眼查App显示，近日，阿斯利康全球研发（北京）有限公司成立，法定代表人为何静，注册资本8000万人民币，经营范围包括细胞技术研发和应用、人体基因诊断与治疗技术开发、人体干细胞技术开发和应用等。股东信息显示，该公司由阿斯利康大陆有限公司全资持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507011514539795915e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507011514539795915e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU0320765992.SGD","LU2456880835.USD","LU0109394709.USD","LU2462157665.USD","BK4588","LU2236285917.USD","LU1829250122.USD","AZN","LU2417539215.USD","BK4585","LU0889565916.HKD","BK4007"],"gpt_icon":0},{"id":"2548568029","title":"9款重磅疗法上市！2025上半年获批肺癌新药全盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=2548568029","media":"药时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548568029?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 12:44","pubTimestamp":1751345064,"startTime":"0","endTime":"0","summary":"恒瑞与百济神州HER2靶向新药获批上市MNC与本土创新药企正面交锋ADC与双抗成研发焦点2025年上半年的新药获批潮，彻底改变了肺癌治疗领域的产业竞争格局。从\"精准治疗\"到\"治愈可能\"研发管线勾勒下一个突破点2025年上半年的9款新药上市，只是肺癌治疗革命的序幕。结 语站在2025年中节点回望，肺癌治疗领域的突破速度令人惊叹。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701124740a4c8199d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701124740a4c8199d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2417539215.USD","LU2462157665.USD","BK4568","LU0889565916.HKD","LU1829250122.USD","LU0109394709.USD","BK4588","LU2456880835.USD","LU0320765992.SGD","BK4007","AZN","LU2236285917.USD","BK4585"],"gpt_icon":0},{"id":"2548336029","title":"辉瑞6月30日成交额为10.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548336029","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548336029?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 12:29","pubTimestamp":1751344147,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，辉瑞成交额为10.85亿美元，成交额较昨日增加13.19%，当日成交量为4473.09万股。辉瑞于2025年6月30日涨0.21%，报24.24美元，该股过去5个交易日涨0.87%，年初至今跌5.35%，过去60日涨0.01%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-30|10.85亿|13.19%|4473.09万|#|2025-06-27|9.58亿|23.98%|3952.88万|#|2025-06-26|7.73亿|24.58%|3183.53万|#|2025-06-25|6.21亿|-25.69%|2560.33万|#|2025-06-24|8.35亿|9.14%|3440.42万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701122913a4c813a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701122913a4c813a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505439.SGD","BK4568","IE00BLSP4239.USD","BK4550","SGXZ57979304.SGD","LU1066053197.SGD","BK4534","IE00B19Z3B42.SGD","LU1894683348.USD","IE0002270589.USD","LU0170899867.USD","LU0225284248.USD","LU0985481810.HKD","LU1894683264.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4599","SG9999001176.SGD","SG9999002224.SGD","SG9999001176.USD","LU0306806265.USD","LU0058720904.USD","LU0306807586.USD","BK4007","LU1066051498.USD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","SG9999013999.USD","BK4592","LU0225771236.USD","LU1883839398.USD","IE00BBT3K403.USD","LU0122379950.USD","PFE","LU0234572021.USD","LU0289739699.SGD","SG9999003800.SGD","BK4533","SG9999002232.USD","BK4588","LU1057294990.SGD","LU0321505868.SGD","LU0868494617.USD","IE00BLSP4452.SGD","BK4581","BK4585"],"gpt_icon":0},{"id":"2548029335","title":"诺瓦瓦克斯医药6月30日成交额为2298.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548029335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548029335?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 12:04","pubTimestamp":1751342694,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，诺瓦瓦克斯医药成交额为2298.66万美元，成交额较昨日减少5.87%，当日成交量为360.63万股。诺瓦瓦克斯医药于2025年6月30日跌1.1%，报6.3美元，该股过去5个交易日跌0.16%，年初至今跌21.64%，过去60日涨5.35%。公司认为其疫苗技术有潜力广泛应用于多种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701120455a7278254&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701120455a7278254&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","BK4139","BK4568","BK4588","BK4547","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}